Patents by Inventor Catherine Tribouley
Catherine Tribouley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20070134680Abstract: The invention provides human lipid metabolism molecules (LMM) and polynucleotides which identify and encode LMM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LMM.Type: ApplicationFiled: March 17, 2006Publication date: June 14, 2007Inventors: Y. Tang, Yalda Azimzai, Debopriya Das, Michael Thornton, Dyung Lu, Catherine Tribouley, Henry Yue, Ameena Gandhi, Narinder Chawla, Farrah Khan, Yan Lu, Monique Yao, April Hafalia, Vicki Elliott, Chandra Arvizu, Preeti Lal, Jayalaxmi Ramkumar, Danniel Nguyen, Mariah Baughn
-
Publication number: 20070082341Abstract: The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.Type: ApplicationFiled: January 18, 2006Publication date: April 12, 2007Inventors: Preeti Lal, Monique Yao, Henry Yue, Ameena Gandhi, Y. Tang, Farrah Khan, Danniel Nguyen, Jennifer Policky, Debopriya Das, Jennifer Hillman, Narinder Walia, April Hafalia, Catherine Tribouley
-
Publication number: 20060035331Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.Type: ApplicationFiled: July 27, 2005Publication date: February 16, 2006Inventors: Preeti Lal, Y. Tang, Chandra Arvizu, Monique Yao, Leo Shih, Catherine Tribouley, Dyung Aina Lu, Henry Yue, Farrah Khan, Jennifer Policky, Janice Au-Young, Junming Yang, Lee Harland, Roderick Walsh, Terence Lo, Mark Borowsky
-
Publication number: 20060035315Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.Type: ApplicationFiled: February 23, 2001Publication date: February 16, 2006Applicant: Incyte Genomics, Inc.Inventors: Henry Yue, Y Tang, Preeti Lal, Jennifer Policky, Danniel Nguyen, Janice Au-Young, Monique Yao, Farrah Khan, Narinder Walia, Ameena Gandhi, Catherine Tribouley, Chandra Arvizu, Michael Thornton, Barrie Greene, Roberto Hernandez, Mark Borowsky, Madhu Sanjanwala
-
Publication number: 20060024792Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.Type: ApplicationFiled: October 4, 2005Publication date: February 2, 2006Inventors: Mariah Baughn, Richard Graul, Narinder Chawla, Ameena Gandhi, April Hafalia, Jayalaxmi Ramkumar, Catherine Tribouley, Michael Thornton, Deborah Kallick, Monique Yao, Vicki Elliott, Neil Burford, Farrah Khan, Henry Yue, Yan Lu, Chandra Arvizu, Roopa Reddy, Danniel Nguyen, Ernestine Lee, Dyung Lu, Craig Ison, Roderick Walsh, Jennifer Policky
-
Publication number: 20050239126Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.Type: ApplicationFiled: June 27, 2005Publication date: October 27, 2005Inventors: Stephen Todd, Angelo Delegeane, Ameena Gandhi, Danniel Nguyen, April Hafalia, Liam Kearney, Yan Lu, Ernestine Lee, Narinder Chawla, Debopriya Das, Chandra Arvizu, Monique Yao, Deborah Kallick, Vicki Elliott, Li Ding, Henry Yue, Roopa Reddy, Dyung Lu, Jayalaxmi Ramkumar, Junming Yang, Catherine Tribouley, Neil Burford, Mariah Baughn, Preeti Lal, Mark Borowsky, Farrah Khan, Rajagopal Gururajan, Y. Tang, Janice Au-Young, Bridget Warren, Roberto Hernandez, Brendan Duggan
-
Publication number: 20050227280Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.Type: ApplicationFiled: May 31, 2005Publication date: October 13, 2005Inventors: Angelo Delegeane, Preeti Lal, April Hafalia, Chandra Arvizu, Narinder Chawla, Liam Kearney, Catherine Tribouley, Farrah Khan, Monique Yao, Mariah Baughn, Yalda Azimzai, Vicki Elliott, Danniel Nguyen, Ameena Gandhi, Junming Yang, Roberto Hernandez, Jennifer Policky, Dyung Aina Lu, Roopa Reddy, Henry Yue, Y. Tang
-
Publication number: 20050202478Abstract: The invention provides human phosphodiesterases (HPDE) and polynucleotides which identify and encode HPDE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HPDE.Type: ApplicationFiled: February 2, 2005Publication date: September 15, 2005Inventors: Michael Thornton, Li Ding, Chandra Arvizu, Monique Yao, Catherine Tribouley, Preeti Lal, April Hafalia, Mariah Baughn, Jayalaxmi Ramkumar, Yan Lu, Narinder Chawla
-
Publication number: 20050191690Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.Type: ApplicationFiled: April 7, 2005Publication date: September 1, 2005Inventors: Preeti Lal, Mariah Baughn, April Hafalia, Danniel Nguyen, Ameena Gandhi, Deborah Kallick, Jennifer Griffin, Henry Yue, Farrah Khan, Chandra Arvizu, Dyung M. Lu, Catherine Tribouley, Yan Lu, Narinder Chawla, Richard Graul, Monique Yao, Junming Yang, Jayakaxmi Ramkumar, Janice Au-Young, Vicki Elliott, Roberto Hernandez, Roderick Walsh, Mark Borowsky, Michael Thornton, Ann He
-
Publication number: 20050164275Abstract: The invention provides human phosphodiesterases (HPDE) and polynucleotides which identify and encode HPDE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HPDE.Type: ApplicationFiled: February 3, 2005Publication date: July 28, 2005Inventors: Michael Thornton, Li Ding, Chandra Arvizu, Monique Yao, Catherine Tribouley, Preeti Lal, April Hafalia, Mariah Baughn, Jayalaxmi Ramkumar, Yan Lu, Narinder Chawla
-
Publication number: 20050112745Abstract: The invention provides human transferases (TRNFR) and polynucleotides which identify and encode TRNFR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRNFR.Type: ApplicationFiled: October 29, 2004Publication date: May 26, 2005Inventors: Preeti Lal, Y. Tang, Henry Yue, Neil Burford, Ameena Gandhi, Bridget Warren, Monique Yao, Catherine Tribouley, Mariah Baughn, Ernestine Lee, April Hafalia, Yan Lu, Jennifer Griffin, Madhusudan Sanjanwala, Li Ding
-
Publication number: 20050112565Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.Type: ApplicationFiled: March 16, 2001Publication date: May 26, 2005Inventors: Henry Yue, Dyung Lu, Jennifer Policky, Angelo Delegeane, Catherine Tribouley, Farrah Khan, Janice Au-Young, Olga Bandman, Preeti Lal, Mark Borowsky, Ameena Gandhi, Jennifer Hillman, Y. Tang, Neil Burford, Mariah Baughn, Danniel Nguyen, Monique Yao, Narinder Walia, Ann He, April Hafalia, Yan Lu, Chandra Arvizu
-
Publication number: 20050101529Abstract: The invention provides human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.Type: ApplicationFiled: December 5, 2001Publication date: May 12, 2005Inventors: Henry Yue, Yalda Azimzai, Deborah Kallick, Mariah Baughn, Jennifer Griffin, Anita Swarnakar, Preeti Lal, Narinder Chawla, April Hafalia, Ameena Gandhi, Janice Au-Young, Vicki Elliott, Jayalaxmi Ramkumar, Kavitha Thangavelu, Yan Lu, Bridget Warren, Dyung Lu, Ernestine Lee, Catherine Tribouley, Chandra Arvizu, Angelo Delegeane, Monique Yao, Farrah Khan, Madhusudan Sanjanwala
-
Publication number: 20050079538Abstract: The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.Type: ApplicationFiled: November 30, 2004Publication date: April 14, 2005Inventors: Jennifer Griffin, Monique Yao, Christopher Bruns, Henry Yue, Angelo Delegeane, April Hafalia, Chandra Arvizu, Jennifer Policky, Catherine Tribouley, Mariah Baughn, Danniel Nguyen, Preeti Lal, Y. Tang, Jennifer Hillman, Dyung Lu, Sajeev Batra, Janice Au-Young, Roopa Reddy, Yalda Azimzai
-
Publication number: 20050048479Abstract: The invention provides human adenylyl and guanylyl cyclases (ADGUC) and polynucleotides which identify and encode ADGUC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ADGUC.Type: ApplicationFiled: June 26, 2001Publication date: March 3, 2005Inventors: Ameena Gandhi, Catherine Tribouley, Li Ding, Dyung Lu, Ernestine Lee, Henry Yue, Junming Yang, Mariah Baughn, Michael Thornton, Monique Yao, Narinder Chawla, Y Tang, Vicki Elliott, Yan Lu
-
Publication number: 20040077837Abstract: The invention provides human microtubule-associated proteins and tubulins (MICAPTUB) and polynucleotides which identify and encode MICAPTUB. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MICAPTUB.Type: ApplicationFiled: February 19, 2003Publication date: April 22, 2004Inventors: Henry Yue, Daniel B Nguyen, Catherine Tribouley, Olga Bandman, Y Tom Tang, Preeti G Lal, Narinder K Chawla, Jennifer Policky
-
Publication number: 20020055625Abstract: New members of the TNF and the TNFR superfamily of proteins have been identified. These proteins are promising targets for therapeutic intervention and mimesis. TNF-L and TNFR-L proteins can be used to induce cell death and/or proliferation of cells. Members of these superfamilies have been implicated in a broad variety of disease processes, making them central biological and physiological regulators.Type: ApplicationFiled: June 8, 2001Publication date: May 9, 2002Inventor: Catherine Tribouley
-
Patent number: 6297367Abstract: New members of the TNF and the TNFR superfamily of proteins have been identified. These proteins are promising targets for therapeutic intervention and mimesis. TNF-L and TNFR-L proteins can be used to induce cell death and/or proliferation of cells. Members of these superfamilies have been implicated in a broad variety of disease processes, making them central biological and physiological regulators.Type: GrantFiled: April 5, 1999Date of Patent: October 2, 2001Assignee: Chiron CorporationInventor: Catherine Tribouley